Apollo Global Management, Inc.
APOApollo Global Management, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is in a downtrend (1 weeks in) while the P/BV sits at the 12th percentile of its own 5-year range. Underneath, the last four quarters read improving — profit +148.8% year on year, with the the net margin at 18.7%. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Apollo Global Management, Inc. trades at $125, in a downtrend and 1 weeks into that stage. That is −2.5% against its own 200-day average. It sits at 46% of a 52-week range of $104 to $149. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (3 weeks and counting).
Today the stock is in a downtrend — week 1 of stage 4. At $125 it trades −2.5% versus its 200-day average and sits at 46% of its 52-week range ($104–$149).
Against the market, two honest reads. Cumulative: over the last 10.2 years the stock moved +706% while the S&P 500 moved +255% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (3 weeks and counting; last ahead the week of 2026-08-28) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each $1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Apollo Global Management, Inc. trades at 3.7× P/BV, near the bottom of its own range — cheaper only 12% of the time. Its long-run median P/BV is 4.9×, measured across 5.2 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 3.7× is near the bottom of its own range — cheaper only 12% of the time, against a long-run median of 4.9× measured over 5.2 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about 11% on its equity is worth less per dollar of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
Why the multiple sits where it does: over the past year book value grew while the price moved −14.0% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +14.7%/yr price move, ~+27.5%/yr came from book-value growth and ~−12.8 pp from the multiple (compressing). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the book-value line underneath it, not the multiple.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Apollo Global Management, Inc. reads as deteriorating on its fundamental arc. Deteriorating — profit and EPS growth are shrinking (profit growth −17.5% latest against +301.9% at its 12-quarter best), ROE slipping at 10.4%. The read is built from 12 quarters across 4 curves, on full evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +22.7% | +43.0% | — | — |
| Profit | −15.2% | — | — | — |
| EPS | −24.4% | — | — | — |
| Stock price | −14.0% | +10.7% | +14.7% | +21.4% |
4-Factor Sector Score
37.8/100 — rank 23 of 29 in Asset Management · 80% evidence confidence
Apollo Global Management, Inc. scores 37.8 out of 100 against the 29 companies it is compared with in Asset Management, ranking 23. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 18.3 + 9.4 + 5.8 + 4.3 = 37.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fees from its businesses.
Apollo Global Management, Inc. reported $11.2 B of income in the Jun 26 quarter, +63.7% year on year. Over 4 years it has compounded at 52.3% a year. The last full year, FY25, came in at $32.0 B. The last four reported quarters add to $35.9 B.
FY25 revenue came in at $32.0 B (+22.7% on the year), capping 4 years at 52.3% compound. The latest quarter (Jun 26) printed $11.2 B, +63.7% year on year.
Pace check: the last four quarters averaged +42.0% growth against the decade's 52.3% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +41.2% over the last 4 quarters against +15.9%/yr over the last 8 — accelerating; TTM profit −17.5% vs −22.5%/yr — accelerating.
Net margin Net margin — what the bank keeps of every $100 of revenue after every cost, provision and tax. With big fee businesses in the mix, it is the cleanest margin we can read for this bank.
Apollo Global Management, Inc.'s net margin is 18.7% in the Jun 26 quarter, +6.4 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged −32.0% to 71.8%. The current quarter sits inside that band.
The latest quarter's net margin is 18.7%, +6.4 pp against the same quarter a year ago. Across 5 fiscal years the net margin has ranged −32.0%–71.8%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Apollo Global Management, Inc. earned $2.1 B of net profit in the Jun 26 quarter, +148.8% year on year. Full-year FY25 profit was $5.4 B. The 4-year compound rate is 6.0%. That is 18.7% of the quarter's revenue. The same quarter a year earlier earned $0.8 B. 1 of the last 12 reported quarters were loss-making.
Jun 26 profit was $2.1 B, +148.8% year on year. On the full year, FY25 printed $5.4 B (−15.2%), and the 4-year compound rate is 6.0%.
Why profit moved: revenue contributed +63.7% and the margin +6.4 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit −23.1% vs revenue +42.0%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Apollo Global Management, Inc., so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book and the businesses grow, revenue grows with them. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Apollo Global Management, Inc.'s revenue grew +22.7% in FY25 to $32.0 B, so the book is growing. The latest quarter ran +63.7% year on year. The net margin on that income is 18.7%, +6.4 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY25 revenue was $32.0 B, +22.7% on the year, and the latest quarter ran +63.7% year on year. The net margin on that revenue is 18.7% this quarter (+6.4 pp YoY) — growth with a widening margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — with quarterly loan-quality numbers missing here, revenue growth and margin are the two we watch.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
Apollo Global Management, Inc. earns a return on equity of 13% in FY25. Its trough over the ladder below was −23% in FY22. On the asset side every $100 of the balance sheet earned about $0.94, which is the return before leverage is applied.
FY25 ROE came in at 13%, recovered from a FY22 trough of −23%. On assets, the latest reading is about 0.94% — every $100 the bank deploys earns roughly $0.94 a year. That return is below the bar a bank must clear to compound book value quickly — which is also the honest reason the stock trades where it does.
Why ROE moved: profit compounded 6.0% a year over 4 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Apollo Global Management, Inc. paid $2.15 per share over the last four reported quarters. The most recent declaration was $0.56 for Jun 26. Against the current price of $125 that is a trailing yield of 1.73%, measured on dividends already paid rather than on a forecast.
Apollo Global Management, Inc. paid $2.15 per share across the last four reported quarters, most recently $0.56 for Jun 26. Against the current price of $125 the trailing twelve months work out to 1.73% — trailing dividends measured against today's price, not a forward estimate.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
5.0% of Apollo Global Management, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 6.8 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 5.0% of the float is sold short, and at typical trading volumes it would take about 6.8 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Apollo Global Management, Inc.: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Victory Capital Holdings, Inc.VCTR | 67.4/100Favorable setup76% evidence | LEADER | 25.0/35 Income 64.1% · PAT 29.1% 71% evidence | 16.1/25 ROA 3.6% · ROE 6.4% · GNPA — 68% evidence | 7.6/20 P/BV 2.29× · P/BV÷ROE 0.36 70% evidence | 18.7/20 RS sector 22.7% · RS bench 24.4% · 1Y 54.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 25 + 16.1 + 7.6 + 18.7 = 67.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Principal Financial Group, Inc.PFG | 62.3/100Mixed-positive evidence80% evidence | LEADER | 22.5/35 Income 3.7% · PAT 36.9% 81% evidence | 11.2/25 ROA 0.4% · ROE 13.3% · GNPA — 68% evidence | 14.1/20 P/BV 1.81× · P/BV÷ROE 0.14 70% evidence | 14.5/20 RS sector 11.4% · RS bench 13.1% · 1Y 42.7%10 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 11.2 + 14.1 + 14.5 = 62.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3SEI Investments CompanySEIC | 59.2/100Mixed-positive evidence60% evidence | LEADER | 18.0/35 Income — · PAT — 26% evidence | 17.0/25 ROA 5.2% · ROE 7.7% · GNPA — 68% evidence | 6.0/20 P/BV 4.21× · P/BV÷ROE 0.55 70% evidence | 18.2/20 RS sector 9.7% · RS bench 11.2% · 1Y 20.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 17 + 6 + 18.2 = 59.2 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 4Ameriprise Financial, Inc.AMP | 57.0/100Mixed-positive evidence64% evidence | BREAKING OUT | 18.3/35 Income 10.6% · PAT 22.4% 62% evidence | 16.4/25 ROA — · ROE 17.9% · GNPA — 34% evidence | 7.3/20 P/BV 6.37× · P/BV÷ROE 0.36 70% evidence | 15.0/20 RS sector 2.6% · RS bench 3.9% · 1Y 10.5%10 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 16.4 + 7.3 + 15 = 57 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5T. Rowe Price Group, Inc.TROW | 55.6/100Mixed-positive evidence80% evidence | ASLEEP | 16.0/35 Income 7% · PAT 9.1% 81% evidence | 20.1/25 ROA 12% · ROE 16.2% · GNPA — 68% evidence | 14.7/20 P/BV 2× · P/BV÷ROE 0.12 70% evidence | 4.8/20 RS sector -8.6% · RS bench -7.3% · 1Y -3.4%5 of 12 weeks ahead 100% evidence |
| Exact sum: 16 + 20.1 + 14.7 + 4.8 = 55.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Brookfield Asset Management Ltd.BAM | 54.8/100Mixed-positive evidence80% evidence | ASLEEP | 28.5/35 Income 31.9% · PAT 32.8% 81% evidence | 17.9/25 ROA 5.6% · ROE 10.2% · GNPA — 68% evidence | 4.4/20 P/BV 9.53× · P/BV÷ROE 0.94 70% evidence | 4.0/20 RS sector -16.5% · RS bench -15.4% · 1Y -24.7%4 of 12 weeks ahead 100% evidence |
| Exact sum: 28.5 + 17.9 + 4.4 + 4 = 54.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -16.5% and the one-year return is -24.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 7Northern Trust CorporationNTRS | 54.8/100Mixed-positive evidence64% evidence | FADING | 22.9/35 Income 15.7% · PAT 29.4% 62% evidence | 12.7/25 ROA — · ROE 6% · GNPA — 34% evidence | 7.1/20 P/BV 2.37× · P/BV÷ROE 0.4 70% evidence | 12.1/20 RS sector 6% · RS bench 7.6% · 1Y 34.3%11 of 12 weeks ahead 100% evidence |
| Exact sum: 22.9 + 12.7 + 7.1 + 12.1 = 54.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8BlackRock, Inc.BLK | 53.6/100Mixed-positive evidence80% evidence | ASLEEP | 17.2/35 Income 26.5% · PAT 2.7% 81% evidence | 18.3/25 ROA 3.4% · ROE 14.9% · GNPA — 68% evidence | 12.8/20 P/BV 2.31× · P/BV÷ROE 0.15 70% evidence | 5.3/20 RS sector -10.4% · RS bench -9.2% · 1Y -9.2%3 of 12 weeks ahead 100% evidence |
| Exact sum: 17.2 + 18.3 + 12.8 + 5.3 = 53.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Affiliated Managers Group, Inc.AMG | 52.3/100Mixed-positive evidence60% evidence | FADING | 20.2/35 Income — · PAT — 26% evidence | 14.8/25 ROA 1.6% · ROE 6.1% · GNPA — 68% evidence | 6.4/20 P/BV 2.94× · P/BV÷ROE 0.48 70% evidence | 10.9/20 RS sector 4.4% · RS bench 5.9% · 1Y 41.2%10 of 12 weeks ahead 100% evidence |
| Exact sum: 20.2 + 14.8 + 6.4 + 10.9 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10StepStone Group Inc.STEP | 52.3/100Thin evidence · provisional55% evidence | TURNING | 23.3/35 Income 69.7% · PAT — 45% evidence | 13.1/25 ROA 6.9% · ROE 0.5% · GNPA — 68% evidence | 9.8/20 P/BV -9.31× · P/BV÷ROE — 10% evidence | 6.1/20 RS sector -18.5% · RS bench -17.7% · 1Y -25.5%3 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 13.1 + 9.8 + 6.1 = 52.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11Corebridge Financial, Inc.CRBG | 52.2/100Thin evidence · provisional55% evidence | BREAKING OUT | 19.1/35 Income 14.6% · PAT -71.3% 45% evidence | 4.8/25 ROA 0% · ROE -0.5% · GNPA — 68% evidence | 9.8/20 P/BV 1.01× · P/BV÷ROE — 10% evidence | 18.5/20 RS sector 9.4% · RS bench 10.7% · 1Y 7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 19.1 + 4.8 + 9.8 + 18.5 = 52.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Blackstone Inc.BX | 51.3/100Mixed-positive evidence80% evidence | ASLEEP | 23.4/35 Income 17.2% · PAT 19.1% 81% evidence | 17.2/25 ROA 5% · ROE 10.8% · GNPA — 68% evidence | 4.5/20 P/BV 9.82× · P/BV÷ROE 0.91 70% evidence | 6.2/20 RS sector -15.2% · RS bench -14.3% · 1Y -34.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 23.4 + 17.2 + 4.5 + 6.2 = 51.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -15.2% and the one-year return is -34.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 13Janus Henderson Group plcJHG | 51.0/100Mixed-positive evidence70% evidence | 20.6/35 Income 24.5% · PAT 100% 71% evidence | 11.7/25 ROA 1.2% · ROE 1.9% · GNPA — 68% evidence | 5.5/20 P/BV 1.53× · P/BV÷ROE 0.81 70% evidence | 13.2/20 RS sector 5.3% · RS bench 0.6% · 1Y 28.9%0 of 1 week ahead to 2026-07-02 70% evidence | |
| Exact sum: 20.6 + 11.7 + 5.5 + 13.2 = 51 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14State Street CorporationSTT | 49.7/100Mixed-negative evidence80% evidence | LEADER | 19.3/35 Income 12.3% · PAT 21.3% 81% evidence | 8.9/25 ROA 0.3% · ROE 3.9% · GNPA — 68% evidence | 6.9/20 P/BV 1.68× · P/BV÷ROE 0.43 70% evidence | 14.6/20 RS sector 17.3% · RS bench 19% · 1Y 61.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 19.3 + 8.9 + 6.9 + 14.6 = 49.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Invesco Ltd.IVZ | 48.9/100Mixed-negative evidence60% evidence | BREAKING OUT | 19.2/35 Income — · PAT — 26% evidence | 10.8/25 ROA 1% · ROE 2.4% · GNPA — 68% evidence | 7.4/20 P/BV 0.94× · P/BV÷ROE 0.39 70% evidence | 11.5/20 RS sector 4.1% · RS bench 5.4% · 1Y 33.7%11 of 12 weeks ahead 100% evidence |
| Exact sum: 19.2 + 10.8 + 7.4 + 11.5 = 48.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Equitable Holdings, Inc.EQH | 45.5/100Mixed-negative evidence76% evidence | BREAKING OUT | 11.8/35 Income -23.4% · PAT -126% 71% evidence | 12.3/25 ROA 0.3% · ROE 24.1% · GNPA — 68% evidence | 3.6/20 P/BV 38.27× · P/BV÷ROE 1.59 70% evidence | 17.8/20 RS sector 9.3% · RS bench 10.6% · 1Y -0.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 11.8 + 12.3 + 3.6 + 17.8 = 45.5 · Decision use: Price leads the evidence: RS versus the benchmark is 10.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 17Franklin Resources, Inc.BEN | 44.1/100Mixed-negative evidence60% evidence | FADING | 17.1/35 Income — · PAT — 26% evidence | 8.6/25 ROA 0.4% · ROE 1.8% · GNPA — 68% evidence | 5.7/20 P/BV 1.44× · P/BV÷ROE 0.8 70% evidence | 12.7/20 RS sector 9.3% · RS bench 11% · 1Y 34%8 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 8.6 + 5.7 + 12.7 = 44.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Blue Owl Capital Inc.OWL | 42.4/100Mixed-negative evidence60% evidence | BREAKING OUT | 19.5/35 Income — · PAT — 26% evidence | 12.3/25 ROA 1.6% · ROE 1.9% · GNPA — 68% evidence | 4.6/20 P/BV 2.94× · P/BV÷ROE 1.55 70% evidence | 6.0/20 RS sector -22.9% · RS bench -22.3% · 1Y -46.5%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.5 + 12.3 + 4.6 + 6 = 42.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Raymond James Financial, Inc.RJF | 41.6/100Mixed-negative evidence80% evidence | FADING | 15.6/35 Income 10.5% · PAT 8.1% 81% evidence | 10.9/25 ROA 0.7% · ROE 4.8% · GNPA — 68% evidence | 6.7/20 P/BV 2.3× · P/BV÷ROE 0.48 70% evidence | 8.4/20 RS sector -5.5% · RS bench -4.3% · 1Y -5.5%9 of 12 weeks ahead 100% evidence |
| Exact sum: 15.6 + 10.9 + 6.7 + 8.4 = 41.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Ares Management CorporationARES | 40.7/100Mixed-negative evidence80% evidence | ASLEEP | 21.7/35 Income 24% · PAT 32.9% 81% evidence | 10.2/25 ROA 0.7% · ROE 3.6% · GNPA — 68% evidence | 3.4/20 P/BV 6.38× · P/BV÷ROE 1.77 70% evidence | 5.4/20 RS sector -15.3% · RS bench -14.5% · 1Y -32.1%6 of 12 weeks ahead 100% evidence |
| Exact sum: 21.7 + 10.2 + 3.4 + 5.4 = 40.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21Blackstone Secured Lending FundBXSL | 39.3/100Mixed-negative evidence62% evidence | TURNING | 9.5/35 Income -22.6% · PAT -19.1% 55% evidence | 11.9/25 ROA — · ROE 3.4% · GNPA — 34% evidence | 8.6/20 P/BV 0.9× · P/BV÷ROE 0.27 70% evidence | 9.3/20 RS sector -8.3% · RS bench -7% · 1Y -10.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 9.5 + 11.9 + 8.6 + 9.3 = 39.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22TPG Inc.TPG | 38.8/100Mixed-negative evidence64% evidence | BREAKING OUT | 17.1/35 Income 11.5% · PAT 100% 71% evidence | 4.2/25 ROA -0.8% · ROE -3.4% · GNPA — 68% evidence | 9.4/20 P/BV 5.73× · P/BV÷ROE — 10% evidence | 8.1/20 RS sector -14.5% · RS bench -13.8% · 1Y -27.2%6 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 4.2 + 9.4 + 8.1 = 38.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Apollo Global Management, Inc.this pageAPO | 37.8/100Mixed-negative evidence80% evidence | ASLEEP | 18.3/35 Income 41.2% · PAT -17.5% 81% evidence | 9.4/25 ROA 0.5% · ROE 5.5% · GNPA — 68% evidence | 5.8/20 P/BV 3.24× · P/BV÷ROE 0.59 70% evidence | 4.3/20 RS sector -9.9% · RS bench -8.8% · 1Y -14%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 9.4 + 5.8 + 4.3 = 37.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24KKR & Co. Inc.KKR | 34.2/100Adverse evidence80% evidence | ASLEEP | 17.4/35 Income 31.1% · PAT 13.5% 81% evidence | 6.9/25 ROA 0.1% · ROE 1.5% · GNPA — 68% evidence | 4.2/20 P/BV 2.65× · P/BV÷ROE 1.77 70% evidence | 5.7/20 RS sector -17.2% · RS bench -16.4% · 1Y -35%4 of 12 weeks ahead 100% evidence |
| Exact sum: 17.4 + 6.9 + 4.2 + 5.7 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Blue Owl Capital CorporationOBDC | 31.2/100Adverse evidence62% evidence | TURNING | 9.0/35 Income -11% · PAT -50.5% 55% evidence | 9.9/25 ROA — · ROE 0.5% · GNPA — 34% evidence | 4.8/20 P/BV 0.77× · P/BV÷ROE 1.53 70% evidence | 7.5/20 RS sector -12.8% · RS bench -11.6% · 1Y -20.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 9 + 9.9 + 4.8 + 7.5 = 31.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Brookfield CorporationBN | 26.2/100Adverse evidence80% evidence | ASLEEP | 12.9/35 Income 1.8% · PAT 21% 81% evidence | 8.7/25 ROA 0.7% · ROE 0.4% · GNPA — 68% evidence | 3.8/20 P/BV 2.24× · P/BV÷ROE 5.6 70% evidence | 0.8/20 RS sector -22.7% · RS bench -21.6% · 1Y -22.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.9 + 8.7 + 3.8 + 0.8 = 26.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27The Carlyle Group Inc.CG | 22.8/100Adverse evidence64% evidence | ASLEEP | 5.9/35 Income -28.9% · PAT -44% 71% evidence | 5.9/25 ROA 0.3% · ROE -2.1% · GNPA — 68% evidence | 9.6/20 P/BV 3.22× · P/BV÷ROE — 10% evidence | 1.4/20 RS sector -28.5% · RS bench -27.6% · 1Y -41.3%2 of 12 weeks ahead 100% evidence |
| Exact sum: 5.9 + 5.9 + 9.6 + 1.4 = 22.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28Pershing Square Inc.PS | 57.5/100Thin evidence · provisional42% evidence | BREAKING OUT | 29.2/35 Income 68.8% · PAT 100% 71% evidence | 8.3/25 ROA 1% · ROE -35.8% · GNPA — 68% evidence | 10.0/20 P/BV — · P/BV÷ROE — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —3 of 8 weeks ahead 0% evidence |
| Exact sum: 29.2 + 8.3 + 10 + 10 = 57.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 29Ares Capital CorporationARCC | 42.3/100Thin evidence · provisional46% evidence | TURNING | 16.5/35 Income — · PAT — 10% evidence | 10.4/25 ROA — · ROE 1.2% · GNPA — 34% evidence | 5.9/20 P/BV 0.96× · P/BV÷ROE 0.8 70% evidence | 9.5/20 RS sector -8% · RS bench -6.7% · 1Y -10.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.5 + 10.4 + 5.9 + 9.5 = 42.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Apollo Global Management, Inc.'s stock price today?
Apollo Global Management, Inc. trades at $125, −14.0% over the past year. The company is valued at $74.0 B. The stock sits at 46% of its 52-week range of $104–$149, −2.5% versus its 200-day average. On the tape, the price is in a downtrend, 1 weeks in. — as of 17 September 2026.
What were Apollo Global Management, Inc.'s latest quarterly results?
Apollo Global Management, Inc. reported total income of $11.2 B and net profit of $2.1 B for the Jun 26 quarter. Income rose 63.7% and profit rose 148.8% year on year. Earnings per share were $2.15. The net margin was 18.7%, 6.4 pp higher than a year earlier. — as of 17 September 2026.
What is Apollo Global Management, Inc.'s revenue?
Apollo Global Management, Inc. reported revenue of $11.2 B in the Jun 26 quarter, +63.7% year on year. For the full FY25 fiscal year, revenue was $32.0 B (+22.7%). Over the last 4 years revenue compounded at 52.3% a year. — as of 17 September 2026.
What is Apollo Global Management, Inc.'s profit?
Apollo Global Management, Inc. earned $2.1 B of net profit in the Jun 26 quarter, +148.8% year on year. Full-year FY25 profit was $5.4 B. The net margin ran 18.7% in the latest quarter. — as of 17 September 2026.
What is Apollo Global Management, Inc.'s market cap?
Apollo Global Management, Inc.'s market capitalisation is $74.0 B at a stock price of $125. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 17 September 2026.
What is Apollo Global Management, Inc.'s P/BV ratio?
Apollo Global Management, Inc. trades at a P/BV of 3.7×, at the 12th percentile of its own 5-year range, against a long-run median of 4.9×. This is a comparison with the stock's own history, not a value call — as of 17 September 2026.
Does Apollo Global Management, Inc. pay a dividend?
Yes — Apollo Global Management, Inc. declared $0.56 per share for Jun 26, and $2.15 per share across the last four reported quarters. — as of 17 September 2026.
What is Apollo Global Management, Inc.'s dividend per share?
Apollo Global Management, Inc.'s most recently declared dividend is $0.56 per share for Jun 26, giving $2.15 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 17 September 2026.
What is Apollo Global Management, Inc.'s dividend yield?
Apollo Global Management, Inc.'s trailing dividend yield is 1.73%: $2.15 declared per share across the last four reported quarters, against a share price of $125. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 17 September 2026.
Is Apollo Global Management, Inc. overvalued?
On its own history, Apollo Global Management, Inc. looks cheap: its P/BV of 3.7× has been cheaper only 12% of the time in 5 years (long-run median 4.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 17 September 2026.
Is Apollo Global Management, Inc. growing?
Yes — Apollo Global Management, Inc. is growing: latest-quarter revenue +63.7% year on year, profit +148.8%, and the net margin +6.4 pp at 18.7%. The 4-year compound rates are 52.3% (revenue) and 6.0% (profit). The earnings engine currently reads: improving — as of 17 September 2026.
How is Apollo Global Management, Inc. performing?
Apollo Global Management, Inc. is in a downtrend, 1 weeks in. Its latest quarter's income rose 63.7% and profit rose 148.8% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 17 September 2026.
What stage is Apollo Global Management, Inc. in?
Deteriorating — profit and EPS growth are shrinking (profit growth −17.5% latest against +301.9% at its 12-quarter best), ROE slipping at 10.4%. The read comes from the last 12 quarters of growth (revenue growth +41.2% latest, profit growth −17.5% latest, eps growth −49.0% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 17 September 2026.
Is Apollo Global Management, Inc. in an uptrend?
No — the price is in a downtrend (week 1 of stage 4), trading −2.5% versus its 200-day average and at 46% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 17 September 2026.
Is Apollo Global Management, Inc. beating the market?
Not lately — on a trailing-13-week view Apollo Global Management, Inc. is currently behind the S&P 500 (3 weeks and counting; last ahead the week of 2026-08-28), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.2 years the stock moved +706% against the S&P 500's +255% — ahead of the index over the full window. — as of 17 September 2026.
Will Apollo Global Management, Inc.'s stock price go up?
This page publishes no price forecast for Apollo Global Management, Inc. What it measures instead: the stock price is $125, the price is in a downtrend 1 weeks in. Its P/BV of 3.7× sits at the 12th percentile of its own 5-year range. — as of 17 September 2026.
Is the market betting against Apollo Global Management, Inc.?
Somewhat — short interest is 5.0% of Apollo Global Management, Inc.'s tradable float, about 6.8 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 17 September 2026.
Where is Apollo Global Management, Inc. in its business cycle?
Apollo Global Management, Inc.'s FY25 net margin was 16.8%, against a 5-year band of −32.0%–71.8%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 18.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 17 September 2026.
What could break the Apollo Global Management, Inc. story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 17 September 2026.
Is Apollo Global Management, Inc. a stock worth studying right now?
This is not investment advice. The machine read: Apollo Global Management, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 17 September 2026.
Not SEBI Registered !! Not Investment advice !!